☆ 4.2 Review

Pks 13 inhibitors-a promising target for future antitubercular agents

MEDICINAL CHEMISTRY RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis

Yanpeng Cai et al.

Summary: This study synthesized and evaluated 36 N-phenylindole derivatives for their antitubercular activity. Compounds 45 and 58 were discovered to have potent inhibitory activity against Mtb H37Rv, with high affinity to the Pks13-TE domain.

MOLECULES (2022)

Add to Collection

Article Infectious Diseases

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Simon Tiberi et al.

LANCET INFECTIOUS DISEASES (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13

Anup Aggarwal et al.

CELL (2017)

Add to Collection

Article Chemistry, Multidisciplinary

beta-lactones as privileged structures for the active-site labeling of versatile bacterial

Thomas Boettcher et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)

Add to Collection

Pks 13 inhibitors-a promising target for future antitubercular agents

Related references

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13

beta-lactones as privileged structures for the active-site labeling of versatile bacterial

Export Citation

Share Paper